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Abstract 23 
We conducted a molecular study of MRSA isolated in Swiss hospitals, including the first five 24 
consecutive isolates recovered from blood cultures and the first ten isolates recovered from 25 
other sites in newly identified carriers. Among 73 MRSA isolates, 44 different Double Locus 26 
Sequence Typing (DLST) types and 32 spa types were observed. Most isolates belonged to 27 
the NewYork/Japan, the UK-EMRSA-15, the South German and the Berlin clones. In a 28 
country with a low to moderate MRSA incidence, inclusion of non-invasive isolates allowed a 29 
more accurate description of the diversity. 30 
 31 
Research note 32 
According to the European Antimicrobial Resistance Surveillance Network (EARS-Net) data 33 
(www.ecdc.europa.eu), the proportion of invasive Staphylococcus aureus isolates that were 34 
found to be methicillin-resistant (MRSA) in European countries varied from below 5% to 35 
more than 50% in 2010. Switzerland is not included in the EARS-Net but has a national 36 
surveillance program for antibiotic resistance (www.anresis.ch). Overall the proportion of 37 
MRSA in clinical specimens was 9% in 2010 and 8% in 2011, varying from 4% in Central 38 
Switzerland to 14% in Western Switzerland. 39 
Clonal lineages can be identified by molecular typing. Thus it is possible to follow the 40 
epidemiology and spread of major clones [1, 2]. A molecular epidemiological analysis 41 
conducted in 2006-2007 showed that MRSA spa types had a predominantly regional 42 
distribution in Europe [3]. Switzerland was not included in this study and no nation-wide 43 
molecular data were available since the last national study conducted in 1997 [4]. The 44 
objective of the present study was to assess the current molecular epidemiology of MRSA in 45 
Swiss hospitals. 46 
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Between January and June 2011, we conducted a survey of MRSA isolates collected in five > 47 
500-bed Swiss hospitals (Basel, Bern, Lausanne, Luzern, and Zürich). Hospitals from the 48 
Italian-speaking region (Ticino) were also included and considered as one center. 49 
Participating hospitals had an incidence of new MRSA cases varying from below 1 to 18 per 50 
1000 admissions (Table 1). Laboratories of participating centers were asked to collect up to 51 
five consecutive MRSA isolates from blood cultures in individual patients and the first ten 52 
consecutive MRSA isolates from clinical samples other than blood or from screening samples 53 
in newly identified MRSA carriers (one isolate per carrier). All isolates were sent to one 54 
reference center (Lausanne). Molecular analysis of MRSA strains was done by Double Locus 55 
Sequence Typing (DLST, a method based on the analysis of the highly variable regions of the 56 
clfB and spa genes) [5], spa-typing [6], and SCCmec typing [7]. The presence of Panton-57 
Valentine leukocidin (PVL) genes was also investigated as described previously [8].  58 
A total of 74 isolates were sent to the reference center: 14 isolates from blood cultures (zero to 59 
five per center) and 60 isolates from clinical or screening samples (ten per center). One isolate 60 
was found to be mecA negative (probable borderline oxacillin-resistant S. aureus; BORSA) 61 
and was excluded from the analysis. Depending on the hospitals’ MRSA incidence, nine days 62 
to 3 months were needed to obtain isolates from ten newly identified patients.  63 
Median age of patients was 63 years (range 1 to 99). Forty-eight (66%) were males. At the 64 
time of bacteraemia or first MRSA identification, 35 patients were hospitalized in wards, 7 in 65 
ICUs, 21 in emergency rooms or outpatient clinic; information was missing for 10 patients. 66 
Among the 14 patients with MRSA bacteraemia, 4 (29%) died within 14 days (all-cause 67 
mortality); ten episodes (71%) were hospital-onset bacteraemia. 68 
Among the 73 MRSA isolates, 44 different DLST types (3 to 11 per hospital) and 32 spa 69 
types (2 to 9 per hospital) were observed (Table 1). Only 10 DLST types were shared by more 70 
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than one patient (2 to 12 patients). Nine different DLST types were found among the 14 71 
MRSA strains isolated from blood cultures, whereas 38 different DLST types were found in 72 
the 59 other isolates. 73 
DLST types were compared to typing data of international clones [7, 8]. At least 62 out of 74 74 
(84%) MRSA isolates were related to 11 international clones (Table 2). Most of them 75 
belonged to the New York/Japan (ST5/105-SCCmec II- PVL neg; n=16), the UK-EMRSA-15 76 
(ST22-IV-neg; n=15), the South German (ST228-I-neg; n=14) and the Berlin (ST45-IV-neg; 77 
n=4) clones. These data are consistent with the major international clones recovered in Europe 78 
[2]. However, the major clones currently observed in Swiss hospitals were different than those 79 
observed in 1997, except for the Berlin clone [9]. This illustrates a change in the molecular 80 
epidemiology of MRSA in Switzerland. 81 
The genetic diversity encountered within each center varied according to the local 82 
epidemiology of MRSA. In the hospital with the highest MRSA incidence, 12 out of 15 83 
isolates had the same DLST type indicating a large clonal outbreak in this center. In contrast, 84 
hospitals with a lower incidence showed a higher genetic diversity, suggesting a non-clonal 85 
spread of MRSA in these centers. 86 
In this study, MRSA isolates were collected in few eligible centers with a low to moderate 87 
MRSA incidence during a limited period of time. Thus, only few invasive isolates were 88 
analyzed. Inclusion of non-invasive isolates allowed more isolates to be collected and to 89 
obtain a more accurate description of the diversity. Moreover, consecutive isolates were 90 
collected and the diversity observed in a hospital facing a clonal MRSA outbreak (such as 91 
center 1) was probably not representative of the real diversity observed year-round. 92 
This study suggests that a national surveillance program could be easily implemented. 93 
Molecular analysis of ten isolates per center per year recovered throughout the whole year 94 
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should reflect the diversity of locally circulating MRSA clones. Only isolates of newly 95 
diagnosed MRSA cases (carriers or infected patients) should be included to better describe the 96 
incidence of circulating clones at the present time. DLST method allows the simultaneous 97 
analysis of 96 isolates in three days for an estimated cost of 20 euros per isolate and is 98 
therefore well suited for that purpose. 99 
In conclusion, this study represents a recent update on the genetic diversity of MRSA 100 
observed in Switzerland. At least 11 international clones were recovered from the six 101 
participating centers. The small number of invasive isolates recovered in centers with a low 102 
MRSA incidence would not have allowed an accurate description of the local diversity. 103 
Adding none-invasive isolates represented a good alternative in settings with low MRSA 104 
incidence. 105 
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Table 1. Epidemiological data of participating centers 148 
Center  1 2 3 4 5 6 Total 
Admissions (n)* 36112 37958 31149 34630 38924 36454 215227 
New MRSA cases/1000 
admissions* 18.05 0.63 1.09 1.24 1.95 1.34 
 
4.15 
Bacteremia due to 
MRSA/1000 adm.*  1.27 0.11 0.06 0.06 0.18 0.03 
 
0.29 
MRSA isolates (n)  15 13 10 10 15 10 73 
     Blood cultures 5 3 0 1 5 0 14 
     Other** 10 10 10 9 10 10 59 
DLST types (n)  3 9 10 10 11 9 44 
spa types (n)  2 9 9 8 8 9 32 
* in 2010 
** including screening samples 
 
 149 
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Table 2. International clones recovered in Switzerland. 
International clone (ST, SCCmec, PVL) Centers DLST types (n) spa types 
New York/Japan (ST5/105-II-neg) 1, 2, 3, 4, 5, 6 2-2(9) t002 
  2-80(3) t003 
  2-414(1) t586 
  586-2(1) t002 
  665-80(1) t003 
  666-80(1) t003 
UK EMRSA-15 (ST22-IV-neg) 1, 4, 5 32-346(2) t8849 
  32-211(2) t515 
  32-623(2) t2231 
  32-627(1) t2440 
  32-341(1) t3130 
  32-626(3) t4640 
  32-628(1) t7478 
  251-211(1) t515 
  663-211(1) t515 
  664-211(1) t515 
South German (ST228-I-neg) 1, 2, 6 4-4(12) t041 
  4-338(1) t579 
  4-618(1) ND 
Berlin (ST45-IV-neg) 2, 3, 4, 6 1-198(1) t050 
  121-198(1) t050 
  641-37(1) t015 
  389-11(1) t065 
European CA-MRSA (ST80-IV-pos) 4, 6 7-26 (2) t044 
  646-26 (1) t044 
WA-MRSA-2 (ST88-IV-pos) 2, 3 69-63 (1) t786 
  604-409 (1) t692 
  653-287 (1) t690 
Lyon (ST8-IV-neg) 3 658-3 (1) t008 
  100-3 (1) t008 
Brazilian (ST239-IIImerc.-neg) 5 660-30 (2) t037 
WA-MRSA-1 (ST1-IV-neg) 4 5-46 (1) t127 
Southwest pacific (ST30-IV-pos) 2 51-94 (1) t318 
Livestock associated (ST398-V-neg) 4 245-339 (1) t034 
ST = sequence type according to the multilocus sequence typing (MLST) scheme 
n = number of isolates 
ND = not determined 
